Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C72089
http://purl.obolibrary.org/obo/NCIT_C72089
|
|---|---|
| Preferred Name | Bromebric Acid |
| Definitions |
A derivative of bromoacrylic acid with cytostatic and antineoplastic activity. Bromebric acid appears to inhibit purine synthesis, oxidative phosphorylation and DNA synthesis. This agent inhibits tumor cell growth and causes cell cycle arrest. This agent may also have some use in the phrophylaxis of migraine.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A derivative of bromoacrylic acid with cytostatic and antineoplastic activity. Bromebric acid appears to inhibit purine synthesis, oxidative phosphorylation and DNA synthesis. This agent inhibits tumor cell growth and causes cell cycle arrest. This agent may also have some use in the phrophylaxis of migraine. |
|---|---|
| prefLabel | Bromebric Acid
|
| label | Bromebric Acid
|
| Has_Salt_Form | |
| code | C72089
|
| prefixIRI | NCIT:C72089
|
| in_subset | |
| Preferred_Name | Bromebric Acid
|
| FDA_UNII_Code | FGE8818GWA
|
| Contributing_Source | FDA
|
| Chemical_Formula | C11H9BrO4
|
| Maps_To | Bromebric Acid
|
| CAS_Registry | 5711-40-0
|
| NSC Number | 104801
|
| Legacy Concept Name | Bromebric_Acid
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| Semantic_Type | Pharmacologic Substance
|
| UMLS_CUI | C0054091
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |